Rafferty Asset Management, LLC

Position in PGEN — Precigen, Inc.

CIK 1389426 New York, NY

Position in PGEN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,235,350

-$328,814 QoQ

Shares Held

319,212

-14.7% QoQ

Ownership

0.090%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Rafferty Asset Management, LLC holds $408,627,656 across 136 Biotechnology names. PGEN ranks #89 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	54,572	$24,368,580
2	REGN	Regeneron Pharmaceuticals, Inc.	29,589	$22,861,644
3	INSM	INSMED Inc	116,069	$18,979,602
4	ALNY	Alnylam Pharmaceuticals, Inc.	50,553	$16,726,471
5	APLS	Apellis Pharmaceuticals, Inc.	180,471	$7,260,348
6	MRNA	Moderna, Inc.	114,194	$5,801,055
7	INCY	Incyte Corp	60,565	$5,700,377
8	MDGL	Madrigal Pharmaceuticals, Inc.	10,452	$5,471,308

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,235,350	319,212	-14.7%	Shares	Sole	2026-05-15
2025-12-31	$1,564,164	374,202	+264.3%	Shares	Sole	2026-02-13
2025-09-30	$337,961	102,724	-78.3%	Shares	Sole	2025-11-12
2021-12-31	$1,758,877	474,091	+170.3%	Shares	Sole	2022-02-10
2021-09-30	$875,111	175,373	-24.3%	Shares	Sole	2021-11-10
2021-06-30	$1,511,427	231,814	-37.7%	Shares	Sole	2021-08-10
2021-03-31	$2,562,074	371,854	+1403.6%	Shares	Sole	2021-05-10
2020-12-31	$252,256	24,731	-74.6%	Shares	Sole	2021-02-10
2020-09-30	$340,504	97,287	+618.5%	Shares	Sole	2020-11-13
2020-03-31	$46,039	13,541	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.